Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ruman Rahman

Showing results (1-10 of 70) with videos related to

Pageof 7
Sort By:
International Journal of Cancer|June 15, 2011
Histone deacetylase inhibition as an anticancer telomerase-targeting strategyRuman Rahman, Richard Grundy
Current Oncology Reports|April 4, 2025
Evolution of Preclinical Models for Glioblastoma Modelling and Drug ScreeningGrace Thomas, Ruman Rahman
Current Oncology Reports|July 15, 2024
Radiogenomics as an Integrated Approach to Glioblastoma Precision MedicineIsabella Sanchez, Ruman Rahman
Biochemical and Biophysical Research Communications|October 10, 2006
Telomerase with mutated catalytic motifs has dominant negative effects on telomerase activity and inhibits cell growthRuman Rahman, Ling Mo, Wei Cui
Biochimica Et Biophysica Acta|May 8, 2009
Cellular immortality in brain tumours: an integration of the cancer stem cell paradigmRuman Rahman, Rachel Heath, Richard Grundy
Pharmaceutics|February 25, 2023
Low-Density Lipoprotein Pathway Is a Ubiquitous Metabolic Vulnerability in High Grade Glioma Amenable for Nanotherapeutic DeliveryAdenike O Adekeye, David Needham, Ruman Rahman
Experimental Gerontology|February 19, 2008
Telomeric 3'-overhang length is associated with the size of telomeresRuman Rahman, Nicholas R Forsyth, Wei Cui
Oncotarget|April 25, 2015
Expression alterations define unique molecular characteristics of spinal ependymomasAnbarasu Lourdusamy, Ruman Rahman, Richard G Grundy
International Journal of Molecular Sciences|November 9, 2017
The Molecular and Phenotypic Basis of the Glioma Invasive Perivascular NicheMohammed Diksin, Stuart J Smith, Ruman Rahman
Journal of Oncology|April 24, 2010
Antiangiogenic therapy and mechanisms of tumor resistance in malignant gliomaRuman Rahman, Stuart Smith, Cheryl Rahman, et al.
Pageof 7

Showing results (1-10 of 70) with videos related to

Sort By:
Pageof 7
International Journal of Cancer|June 15, 2011
Histone deacetylase inhibition as an anticancer telomerase-targeting strategyRuman Rahman, Richard Grundy
Current Oncology Reports|April 4, 2025
Evolution of Preclinical Models for Glioblastoma Modelling and Drug ScreeningGrace Thomas, Ruman Rahman
Current Oncology Reports|July 15, 2024
Radiogenomics as an Integrated Approach to Glioblastoma Precision MedicineIsabella Sanchez, Ruman Rahman
Biochemical and Biophysical Research Communications|October 10, 2006
Telomerase with mutated catalytic motifs has dominant negative effects on telomerase activity and inhibits cell growthRuman Rahman, Ling Mo, Wei Cui
Biochimica Et Biophysica Acta|May 8, 2009
Cellular immortality in brain tumours: an integration of the cancer stem cell paradigmRuman Rahman, Rachel Heath, Richard Grundy
Pharmaceutics|February 25, 2023
Low-Density Lipoprotein Pathway Is a Ubiquitous Metabolic Vulnerability in High Grade Glioma Amenable for Nanotherapeutic DeliveryAdenike O Adekeye, David Needham, Ruman Rahman
Experimental Gerontology|February 19, 2008
Telomeric 3'-overhang length is associated with the size of telomeresRuman Rahman, Nicholas R Forsyth, Wei Cui
Oncotarget|April 25, 2015
Expression alterations define unique molecular characteristics of spinal ependymomasAnbarasu Lourdusamy, Ruman Rahman, Richard G Grundy
International Journal of Molecular Sciences|November 9, 2017
The Molecular and Phenotypic Basis of the Glioma Invasive Perivascular NicheMohammed Diksin, Stuart J Smith, Ruman Rahman
Journal of Oncology|April 24, 2010
Antiangiogenic therapy and mechanisms of tumor resistance in malignant gliomaRuman Rahman, Stuart Smith, Cheryl Rahman, et al.
Pageof 7